Mark A. Hillman
Hillman Value Fund
Mark A. Hillman CVS Health Corp stake
total: 75
Hillman Value Fund CVS trades
- Total transactions:
- 10
- New positions:
- 1
- Added:
- 4
- Reduced:
- 5
- Held since:
- 2020 Q1
- Held for:
- 25 quarters
- Latest activity:
- 2025 Q4
According to 2026 Q1 report, Mark A. Hillman holds 31,500 CVS Health Corp (CVS) shares with a market value of roughly $2.26M accounting for 2.73% of the overall portfolio. To date, the estimated cost basis is nearly $64.74 for "buy" trades and estimated average "sell" price is $76.41. Hillman Value Fund first purchased CVS in 2020 Q1, initially acquiring 40,000 shares. Since the initial investment in CVS Health Corp (CVS), Hillman Value Fund has made 9 more transactions.
When did Mark A. Hillman buy CVS Health Corp (CVS)?
Mark A. Hillman first invested in CVS Health Corp (CVS) in 2020 Q1 at the reported quarter-end price of $59.33 per share.
What's the cost basis of Hillman Value Fund's CVS stake?
The estimated cost basis for CVS Health Corp (CVS) stake is around $64.74 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $64.74
- Weighted AVG sell price:
- $76.41
Mark A. Hillman's historical trades in CVS Health Corp
10 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q4
|
2.67%
|
31,500
|
$79.36
|
$2,499,840
|
-13.22% (-4,800)
|
-0.36%
|
|
2025 Q3
|
2.60%
|
36,300
|
$75.39
|
$2,736,657
|
-21.43% (-9,900)
|
-0.63%
|
|
2025 Q2
|
2.69%
|
46,200
|
$68.98
|
$3,186,876
|
-12.99% (-6,900)
|
-0.33%
|
|
2025 Q1
|
2.53%
|
53,100
|
$67.75
|
$3,597,525
|
-35.24% (-28,900)
|
-0.93%
|
|
2023 Q3
|
2.75%
|
82,000
|
$69.82
|
$5,725,240
|
+26.15% (+17,000)
|
+0.57%
|
|
2022 Q1
|
2.67%
|
65,000
|
$101.21
|
$6,578,650
|
-15.58% (-12,000)
|
-0.52%
|
|
2021 Q1
|
3.35%
|
77,000
|
$75.23
|
$5,792,710
|
+22.22% (+14,000)
|
+0.61%
|
|
2020 Q4
|
3.27%
|
$68.30
|
+26.00% (+13,000)
|
|||
|
2020 Q3
|
2.81%
|
$58.40
|
+25.00% (+10,000)
|
|||
|
2020 Q1
|
3.31%
|
$59.33
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.